Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study

OBJECTIVE: To estimate the effectiveness of mRNA covid-19 vaccines against symptomatic infection and severe outcomes (hospital admission or death). DESIGN: Test negative design study. SETTING: Ontario, Canada between 14 December 2020 and 19 April 2021. PARTICIPANTS: 324 033 community dwelling people...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Hannah, He, Siyi, Nasreen, Sharifa, Sundaram, Maria E, Buchan, Sarah A, Wilson, Sarah E, Chen, Branson, Calzavara, Andrew, Fell, Deshayne B, Austin, Peter C, Wilson, Kumanan, Schwartz, Kevin L, Brown, Kevin A, Gubbay, Jonathan B, Basta, Nicole E, Mahmud, Salaheddin M, Righolt, Christiaan H, Svenson, Lawrence W, MacDonald, Shannon E, Janjua, Naveed Z, Tadrous, Mina, Kwong, Jeffrey C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377789/
https://www.ncbi.nlm.nih.gov/pubmed/34417165
http://dx.doi.org/10.1136/bmj.n1943

Ejemplares similares

Ejemplares similares